US Bancorp DE cut its position in Ambev S.A. (NYSE:ABEV - Free Report) by 81.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 164,913 shares of the company's stock after selling 706,783 shares during the quarter. US Bancorp DE's holdings in Ambev were worth $384,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Bank of America Corp DE grew its stake in Ambev by 201.7% in the 4th quarter. Bank of America Corp DE now owns 26,087,675 shares of the company's stock valued at $48,262,000 after buying an additional 17,440,564 shares during the last quarter. Talaria Asset Management Pty Ltd acquired a new position in Ambev in the 4th quarter valued at $38,602,000. Two Sigma Advisers LP grew its stake in Ambev by 329.6% in the 4th quarter. Two Sigma Advisers LP now owns 16,354,000 shares of the company's stock valued at $30,255,000 after buying an additional 12,546,800 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its stake in Ambev by 101.1% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 15,639,612 shares of the company's stock valued at $29,512,000 after buying an additional 7,862,672 shares during the last quarter. Finally, Private Management Group Inc. grew its stake in Ambev by 6.4% in the 1st quarter. Private Management Group Inc. now owns 15,439,216 shares of the company's stock valued at $35,973,000 after buying an additional 926,982 shares during the last quarter. 8.13% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ABEV has been the topic of a number of research analyst reports. Barclays raised their target price on shares of Ambev from $2.00 to $2.50 and gave the company an "equal weight" rating in a research note on Monday, May 12th. Hsbc Global Res upgraded shares of Ambev to a "hold" rating in a research report on Friday, August 1st. UBS Group raised their price target on shares of Ambev from $2.60 to $2.70 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. HSBC restated a "hold" rating on shares of Ambev in a research report on Friday, August 1st. Finally, Wall Street Zen began coverage on shares of Ambev in a research report on Wednesday, April 23rd. They issued a "buy" rating on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Ambev currently has an average rating of "Hold" and a consensus price target of $2.60.
Read Our Latest Stock Report on ABEV
Ambev Price Performance
Shares of Ambev stock opened at $2.21 on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.80 and a current ratio of 1.11. The firm's 50-day simple moving average is $2.37 and its 200-day simple moving average is $2.29. Ambev S.A. has a twelve month low of $1.76 and a twelve month high of $2.63. The firm has a market cap of $34.82 billion, a P/E ratio of 13.81, a price-to-earnings-growth ratio of 2.44 and a beta of 0.74.
Ambev (NYSE:ABEV - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.03 earnings per share for the quarter, meeting the consensus estimate of $0.03. Ambev had a net margin of 16.18% and a return on equity of 15.39%. The business had revenue of $3.59 billion for the quarter, compared to analyst estimates of $21.84 billion. As a group, research analysts expect that Ambev S.A. will post 0.18 EPS for the current fiscal year.
Ambev Increases Dividend
The company also recently declared a -- dividend, which will be paid on Tuesday, October 14th. Investors of record on Monday, August 11th will be issued a dividend of $0.023 per share. The ex-dividend date of this dividend is Monday, August 11th. This represents a yield of 660.0%. This is an increase from Ambev's previous -- dividend of $0.02. Ambev's payout ratio is 31.25%.
About Ambev
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report